Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 3—March 2005

Ebola Virus Antibody Prevalence in Dogs and Human Risk

Loïs Allela*, Olivier Bourry*, Régis Pouillot†, André Délicat*, Philippe Yaba*, Brice Kumulungui*, Pierre Rouquet*, Jean-Paul Gonzalez‡, and Eric M. Leroy*‡Comments to Author 
Author affiliations: *Centre International de Recherches Médicales de Franceville, Franceville, Gabon; †Centre Pasteur du Cameroun, Yaoundé, Cameroun; ‡Institut de Recherche pour le Développement, Paris, France

Main Article

Table 2

Prevalence rates of Ebola-specific immunoglobulin G antibodies in pet dogs from different areas and villages

Area/village characteristic No. No. positive Seroprevalence* (%) 95% confidence interval (%)
France 102 2 2 0.2–6.9
Major towns (Libreville and Port Gentil) 79 7 8.9 3.6–17.4
Mekambo 99 15 15.2 8.7–23.8
Ebola virus–epidemic area (villages) 159 40 25.2 18.6–32.6
Villages with human cases 92 25 27.2 18.4–37.4
Villages without human cases 67 15 22.4 13.1–34.2
Villages with human cases and animal source 66 21 31.8 20.9–44.4
Villages with human cases, without animal source
*Seroprevalence rates were compared by using the Fisher exact test with a 0.05 confidence level.

Main Article

¹Loïs Allela and Olivier Bourry contributed equally to this work.

Page created: April 25, 2012
Page updated: April 25, 2012
Page reviewed: April 25, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.